{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:21:09Z","timestamp":1793643669643,"version":"4.5.1"},"reference-count":124,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.gendis.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T22:29:36Z","timestamp":1555453776000},"page":"109-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":545,"title":["Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review"],"prefix":"10.1016","volume":"6","author":[{"given":"Preeti","family":"Pachori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragini","family":"Gothalwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gendis.2019.04.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, No drugs: No ESKAPE! An update from the infectious diseases society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gendis.2019.04.001_bib2","series-title":"25 Years of Progress and Innovation in Intensive Care Medicine","first-page":"199","article-title":"Multidrug resistant infections in the ICU: mechanisms, prevention and treatment","author":"Carlet","year":"2007"},{"key":"10.1016\/j.gendis.2019.04.001_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijantimicag.2006.10.017","article-title":"Antimicrobial treatment for intensive care unit (ICU) infections including the role of the infectious disease specialist","volume":"29","author":"Esposito","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.gendis.2019.04.001_bib4","first-page":"200","article-title":"Ventilator associated pneumonia in a tertiary care intensive care unit: analysis of incidence, risk factors and mortality","volume":"18","author":"Ranjan","year":"2007","journal-title":"Indian J Crit Care Med"},{"issue":"12","key":"10.1016\/j.gendis.2019.04.001_bib5","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1093\/jac\/dku307","article-title":"Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in London","volume":"69","author":"Moore","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.gendis.2019.04.001_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of antimicrobial resistance in ESKAPE pathogens","author":"Santajit","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.gendis.2019.04.001_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2334-9-123","article-title":"In\u00a0vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo b-lactamase-producing Pseudomonas aeruginosa","volume":"9","author":"Oie","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gendis.2019.04.001_bib8","first-page":"130","article-title":"Colistin, an option for treatment of multiple drug resistant Pseudomonas aeruginosa","volume":"20","author":"Memar","year":"2016","journal-title":"Physiol Pharmacol"},{"issue":"4","key":"10.1016\/j.gendis.2019.04.001_bib9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1099\/mic.0.26085-0","article-title":"Identification and characterization of novel pyoverdine synthesis genes in Pseudomonas aeruginosa","volume":"149","author":"Lamont","year":"2003","journal-title":"Microbiol"},{"issue":"6","key":"10.1016\/j.gendis.2019.04.001_bib10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.meegid.2009.08.001","article-title":"Historical evolution and current status of the taxonomy of genus Pseudomonas","volume":"9","author":"Peix","year":"2009","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.gendis.2019.04.001_bib11","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.ajic.2005.03.006","article-title":"Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism","volume":"33","author":"Trautmann","year":"2009","journal-title":"Am J Infect Contr"},{"key":"10.1016\/j.gendis.2019.04.001_bib12","first-page":"317","article-title":"Persistence of microbial communities including Pseudomonas aeruginosa in a hospital environment: a potential health hazard","volume":"10","author":"Abreu","year":"2017","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.gendis.2019.04.001_bib13","series-title":"Lippincott Williams & Wilkins","author":"Engleberg","year":"2007"},{"key":"10.1016\/j.gendis.2019.04.001_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/2049936114543287","article-title":"The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment","volume":"2","author":"Roy","year":"2014","journal-title":"Therapeut Adv Inf Dis"},{"issue":"999","key":"10.1016\/j.gendis.2019.04.001_bib15","first-page":"836","article-title":"Pseudomonas aeruginosa: growth in distilled water from hospitals","volume":"173","author":"Favero","year":"1997","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.gendis.2019.04.001_bib16","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0161-6420(01)00724-2","article-title":"An in\u00a0vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa","volume":"108","author":"Kowalski","year":"2001","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.gendis.2019.04.001_bib17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1086\/502471","article-title":"Survey of knowledge, beliefs, and practices of neonatal intensive care unit healthcare workers regarding nosocomial infections, central venous catheter care, and hand hygiene","volume":"25","author":"Kennedy","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"13","key":"10.1016\/j.gendis.2019.04.001_bib18","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gendis.2019.04.001_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/IDR.S147459","article-title":"Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece","volume":"10","author":"Kritsotakis","year":"2017","journal-title":"Infect Drug Resist"},{"issue":"61","key":"10.1016\/j.gendis.2019.04.001_bib20","first-page":"2671","article-title":"Results from a 13-year prospective cohort study show increased mortality associated with bloodstream infections caused by Pseudomonas aeruginosa compared to other bacteria","volume":"24","author":"Thaden","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gendis.2019.04.001_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/cc11421","article-title":"Year in review 2011: critical care\u2013infection","volume":"16","author":"Afshari","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.gendis.2019.04.001_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/bmj.e3325","article-title":"Ventilator associated pneumonia","volume":"344","author":"Hunter","year":"2012","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.gendis.2019.04.001_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ajic.2007.10.009","article-title":"National prevalence of methicillin resistant Staphylococcus aureus in inpatients at US health care facilities","volume":"35","author":"Jarvis","year":"2007","journal-title":"Am J infect cont"},{"issue":"4","key":"10.1016\/j.gendis.2019.04.001_bib24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s00134-013-2828-9","article-title":"Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients","volume":"39","author":"Tumbarello","year":"2013","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.gendis.2019.04.001_bib25","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/CCM.0000000000000510","article-title":"Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa","volume":"42","author":"Kollef","year":"2014","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.gendis.2019.04.001_bib26","first-page":"1019","article-title":"Ventilator associated pneumonia due to Pseudomonas aeruginosa","volume":"109","author":"Crouch","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.gendis.2019.04.001_bib27","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s10096-010-1004-1","article-title":"Distribution of 16S rRNA methylases among different species of Gram- negative bacilli with high-level resist-ance to aminoglycosides","volume":"29","author":"Zhou","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.gendis.2019.04.001_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1524-4733.2008.00410.x","article-title":"Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China","volume":"12","author":"Zhou","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.gendis.2019.04.001_bib29","first-page":"149","article-title":"Ventilator-associated pneumonia caused by Pseudomonas aeruginosa in intensive care unit: epidemiology and risk factors","volume":"3","author":"Raineri","year":"2014","journal-title":"J Med Microbiol Diagn"},{"issue":"3","key":"10.1016\/j.gendis.2019.04.001_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01704699","article-title":"Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia","volume":"20","author":"Rello","year":"1994","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.gendis.2019.04.001_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s15010-005-4021-8","article-title":"Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms","volume":"33","author":"Leroy","year":"2005","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.gendis.2019.04.001_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2047-2994-3-32","article-title":"Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis","volume":"3","author":"Nathwani","year":"2014","journal-title":"Antimicrob Resist Infect Contr"},{"issue":"2","key":"10.1016\/j.gendis.2019.04.001_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/cc13849","article-title":"Management of Pseudomonas aeruginosa pneumonia: one size does not fit all","volume":"18","author":"Rello","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.gendis.2019.04.001_bib34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10096-009-0850-1","article-title":"Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case-control study","volume":"29","author":"Montero","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.gendis.2019.04.001_bib35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1469-0691.2001.00353.x","article-title":"Nosocomial urinary tract infections: many unresolved questions","volume":"7","author":"Meier","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.gendis.2019.04.001_bib36","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/1469-0691.12089","article-title":"Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance","volume":"9","author":"Horcajada","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.gendis.2019.04.001_bib37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1198-743x.2001.00326.x","article-title":"A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility","volume":"7","author":"Bouza","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.gendis.2019.04.001_bib38","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ajic.2013.02.018","article-title":"Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: sensitivity to antibiotics and risk factors","volume":"41","author":"Djordjevic","year":"2013","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.gendis.2019.04.001_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jiph.2009.08.003","article-title":"Urinary tract infections caused by Pseudomonas aeruginosa: a mini review","volume":"2","author":"Mittal","year":"2009","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1016\/j.gendis.2019.04.001_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/bja\/70.1.22","article-title":"Evidence for dynamic phenomena in residual tracheal tube biofilm","volume":"70","author":"Inglis","year":"1993","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.gendis.2019.04.001_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s003450050159","article-title":"The development of bacterial biofilms on indwelling urethral catheters","volume":"17","author":"Morris","year":"1999","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.gendis.2019.04.001_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3201\/eid0702.010226","article-title":"Biofilms and device-associated infections","volume":"7","author":"Donlan","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.gendis.2019.04.001_bib43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3201\/eid0702.010240","article-title":"Engineering out the risk for infection with urinary catheters","volume":"7","author":"Maki","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.gendis.2019.04.001_bib44","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/00003246-200208000-00034","article-title":"Pilot study of antibiotic cycling in a pediatric intensive care unit","volume":"30","author":"Moss","year":"2002","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.gendis.2019.04.001_bib45","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1183\/09031936.02.00012902","article-title":"Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome","volume":"20","author":"Nseir","year":"2002","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.gendis.2019.04.001_bib46","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1592\/phco.2005.25.10.1353","article-title":"Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options","volume":"25","author":"Obritsch","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.gendis.2019.04.001_bib47","first-page":"1133","article-title":"Pseudomonas aeruginosa : a phenomenon of bacterial resistance","volume":"58","author":"Tanya","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.gendis.2019.04.001_bib48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/AAC.21.2.299","article-title":"Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-super susceptible mutant","volume":"21","author":"Angus","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.gendis.2019.04.001_bib49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0168-6445(99)00039-X","article-title":"Molecular basis of antibiotic resistance and \u03b2-lactamase inhibition by mechanism-based inactivators: perspectives and future direction","volume":"24","author":"Therrien","year":"2000","journal-title":"FEMS Microbiol Rev"},{"issue":"7","key":"10.1016\/j.gendis.2019.04.001_bib50","first-page":"965","article-title":"Clinical approach to the patient with suspected ventilator-associated pneumonia","volume":"50","author":"Vidaur","year":"2005","journal-title":"Respir Care"},{"issue":"1","key":"10.1016\/j.gendis.2019.04.001_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/dkf069","article-title":"Identification of PSE and OXA \u03b2-lactamase genes in Pseudomonas aeruginosa using PCR\u2013restriction fragment length polymorphism","volume":"50","author":"Bert","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.gendis.2019.04.001_bib52","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1128\/AAC.48.4.1168-1174.2004","article-title":"Dynamics and spatial distribution of-lactamase expression in Pseudomonas aeruginosa biofilms","volume":"48","author":"Bagge","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.gendis.2019.04.001_bib53","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1128\/AAC.49.11.4733-4738.2005","article-title":"Molecular mechanisms of beta-lactam resistance mediated by AmpC hyper production in Pseudomonas aeruginosa clinical strains","volume":"49","author":"Juan","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.gendis.2019.04.001_bib54","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A functional classification scheme for beta-lactamases and its correlation with molecular structure","volume":"39","author":"Bush","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.gendis.2019.04.001_bib55","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00134-012-2808-5","article-title":"Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors","volume":"39","author":"Martin-Loeches","year":"2013","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.gendis.2019.04.001_bib56","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/AAC.45.7.1964-1971.2001","article-title":"Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay","volume":"45","author":"Okomoto","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gendis.2019.04.001_bib57","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","article-title":"Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials","volume":"328","author":"Paul","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.gendis.2019.04.001_bib58","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","article-title":"Aminoglycoside resistance in Pseudomonas aeruginosa","volume":"49","author":"Poole","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.gendis.2019.04.001_bib59","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/00000542-200610000-00016","article-title":"Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in presence of recent antibiotic exposure","volume":"105","author":"Rello","year":"2006","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1016\/j.gendis.2019.04.001_bib60","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1128\/AAC.41.10.2113","article-title":"The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide","volume":"4","author":"Dietz","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.gendis.2019.04.001_bib61","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1365-2958.1989.tb00262.x","article-title":"Regulation of enterobacterial cephalosporinase production: the role of a membrane-bound sensory transducer","volume":"3","author":"Honor\u00e9","year":"1989","journal-title":"Mol Microbiol"},{"issue":"41","key":"10.1016\/j.gendis.2019.04.001_bib62","doi-asserted-by":"crossref","first-page":"19688","DOI":"10.2807\/ese.15.41.19688-en","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe","volume":"15","author":"K\u00f6ck","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.gendis.2019.04.001_bib63","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.16.3.430-450.2003","article-title":"Versatility of aminoglycosides and prospects for their future","volume":"16","author":"Vakulenko","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.gendis.2019.04.001_bib64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Res"},{"key":"10.1016\/j.gendis.2019.04.001_bib65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fmicb.2011.00065","article-title":"Pseudomonas aeruginosa: resistance to the max","volume":"2","author":"Poole","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.gendis.2019.04.001_bib66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1074-5521(02)00125-4","article-title":"Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site","volume":"9","author":"Llano-Sotelo","year":"2002","journal-title":"Chem Biol"},{"key":"10.1016\/j.gendis.2019.04.001_bib67","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1093\/clinids\/24.Supplement_1.S46","article-title":"The most frequent aminoglycoside resistance mechanisms \u2013 changes with time and geographic area: a reflection of aminoglycoside usage patterns?","volume":"24","author":"Miller","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.gendis.2019.04.001_bib68","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/315312","article-title":"Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment","volume":"181","author":"MacLeod","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gendis.2019.04.001_bib69","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1128\/AAC.48.6.2069-2074.2004","article-title":"Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates","volume":"48","author":"Yamane","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gendis.2019.04.001_bib70","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.diagmicrobio.2010.07.021","article-title":"Emergence of 16S rRNA methylase gene armA and cocarriage of blaIMP-1 in Pseudomonas aeruginosa isolates from South Korea","volume":"68","author":"Gast Gurung","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.gendis.2019.04.001_bib71","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.1058709","article-title":"Commensal host-bacterial relationships in the gut","volume":"292","author":"Hooper","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gendis.2019.04.001_bib72","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/cc13697","article-title":"Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes","volume":"18","author":"Lu","year":"2014","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.gendis.2019.04.001_bib73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002030000188","article-title":"Pyoverdines: pigments, siderophores and potential taxonomic markers of fluorescent Pseudomonas species","volume":"174","author":"Magiorakos","year":"2000","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.gendis.2019.04.001_bib74","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Liljequist","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.gendis.2019.04.001_bib75","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijantimicag.2007.05.017","article-title":"Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa","volume":"30","author":"Furtado","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.gendis.2019.04.001_bib76","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00134-007-0675-2","article-title":"Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study","volume":"33","author":"Kallel","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.gendis.2019.04.001_bib77","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/AAC.47.3.905-909.2003","article-title":"Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in\u00a0vitro pharmacodynamic model","volume":"47","author":"Gunderson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gendis.2019.04.001_bib78","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.gendis.2019.04.001_bib79","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/mdr.2014.0006","article-title":"In\u00a0Vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa","volume":"20","author":"D'Souza","year":"2010","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.gendis.2019.04.001_bib80","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1185\/03007995.2015.1018989","article-title":"Colistin, mechanisms and prevalence of resistance","volume":"31","author":"Bialvaei","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.gendis.2019.04.001_bib81","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijantimicag.2009.03.009","article-title":"Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies","volume":"34","author":"Falagas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"10.1016\/j.gendis.2019.04.001_bib82","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s11255-017-1627-6","article-title":"Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully","volume":"49","author":"Patwardhan","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.gendis.2019.04.001_bib83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s101560200004","article-title":"Effectiveness of fosfomycin combined with other antimicrobial agents against multidrug-resistant Pseudomonas aeruginosa isolates using the efficacy time index assay","volume":"8","author":"Okazaki","year":"2002","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.gendis.2019.04.001_bib84","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000100811","article-title":"Role of ciprofloxacin in its synergistic effect with fosfomycin on drugresistant strains of Pseudomonas aeruginosa","volume":"53","author":"Yamada","year":"2007","journal-title":"Chemother"},{"issue":"4","key":"10.1016\/j.gendis.2019.04.001_bib85","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1086\/503175","article-title":"Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram","volume":"27","author":"Mizuta","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.gendis.2019.04.001_bib86","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1086\/504486","article-title":"Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species","volume":"43","author":"Rahal","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"308","key":"10.1016\/j.gendis.2019.04.001_bib87","first-page":"1471","article-title":"Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia","volume":"12","author":"Par","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gendis.2019.04.001_bib88","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/jac\/dkf211","article-title":"Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs","volume":"50","author":"Fish","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.gendis.2019.04.001_bib89","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/AAC.46.4.1105-1107.2002","article-title":"Synergistic activities of macrolides antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis","volume":"46","author":"Saiman","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.gendis.2019.04.001_bib90","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ja.2015.27","article-title":"In\u00a0vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa","volume":"68","author":"Di","year":"2015","journal-title":"J Antibiot"},{"issue":"8","key":"10.1016\/j.gendis.2019.04.001_bib91","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/infdis\/jiu603","article-title":"Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia","volume":"21","author":"Louie","year":"2015","journal-title":"JID (J Infect Dis)"},{"issue":"9","key":"10.1016\/j.gendis.2019.04.001_bib92","doi-asserted-by":"crossref","first-page":"856","DOI":"10.5897\/AJMR2013.6477","article-title":"Synergic bactericidal activity of novel antibiotic combinations against extreme drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"8","author":"Aboulmagd","year":"2014","journal-title":"Afr J Microbiol Res"},{"issue":"4","key":"10.1016\/j.gendis.2019.04.001_bib93","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1378\/chest.117.4.1017","article-title":"Bacterial pneumonia in hospitalized patients with HIV infection: the pulmonary complications, ICU support, and prognostic factors of hospitalized patients with HIV (PIP) study","volume":"117","author":"Afessa","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.gendis.2019.04.001_bib94","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.34.1.40","article-title":"Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis","volume":"34","author":"Gentry","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.gendis.2019.04.001_bib95","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1054\/mehy.2001.1522","article-title":"Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics","volume":"58","author":"Ahmad","year":"2002","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.gendis.2019.04.001_bib96","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/jhin.2002.1277","article-title":"Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections","volume":"52","author":"Allegranzi","year":"2002","journal-title":"J Hosp Infect"},{"issue":"16","key":"10.1016\/j.gendis.2019.04.001_bib97","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.162.16.1849","article-title":"Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis","volume":"162","author":"Arancibia","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.gendis.2019.04.001_bib98","series-title":"Pseudomonas aeruginosa: Infections and Treatment","author":"Baltch","year":"1994"},{"issue":"10","key":"10.1016\/j.gendis.2019.04.001_bib99","first-page":"824","article-title":"Pseudomonas aeruginosa: acute lung injury or ventilator associated pneumonia?","volume":"76","author":"Berra","year":"2010","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.gendis.2019.04.001_bib100","first-page":"256","article-title":"Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"48","key":"10.1016\/j.gendis.2019.04.001_bib101","first-page":"1087","article-title":"Pseudomonas dermatitis\/folliculitis associated with pools and hot tubs--Colorado and Maine, 1999-2000","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.gendis.2019.04.001_bib102","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archinte.160.4.501","article-title":"Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes","volume":"160","author":"Chatzinikolaou","year":"2002","journal-title":"Arch Intern Med"},{"issue":"36","key":"10.1016\/j.gendis.2019.04.001_bib103","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3126\/jnhrc.v15i2.18185","article-title":"Surgical site infections and antimicrobial resistance pattern","volume":"15","author":"Chaudhary","year":"2017","journal-title":"J Nepal Health Res Counc"},{"key":"10.1016\/j.gendis.2019.04.001_bib104","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/499406","article-title":"The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs","volume":"42","author":"Cosgrove","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.gendis.2019.04.001_bib105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40121-016-0141-y","article-title":"In\u00a0vitro activity of ceftolozane\/tazobactam alone or with an aminoglycoside against multi-drug- resistant Pseudomonas aeruginosa from pediatric cystic fibrosis patients","volume":"6","author":"Dassner","year":"2017","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.gendis.2019.04.001_bib106","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.47.3.972-978.2003","article-title":"Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1","volume":"47","author":"Dean","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.gendis.2019.04.001_bib107","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1128\/AAC.41.10.2113","article-title":"The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide","volume":"4","author":"Dietz","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.gendis.2019.04.001_bib108","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1128\/AAC.00443-07","article-title":"High prevalence of metallo-\u03b2-lactamase and 16S rRNA methylase coproduction among imipenem- resistant Pseudomonas aeruginosa isolates in Brazil","volume":"51","author":"Doi","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.gendis.2019.04.001_bib109","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2222-1808(13)60005-5","article-title":"CT gene modulates differential expression of chitinase gene under variant habitats in Vibrio's","volume":"3","author":"Verma","year":"2013","journal-title":"Asian Pac J Trop Dis"},{"key":"10.1016\/j.gendis.2019.04.001_bib110","article-title":"Hospital-acquired infections caused by antibiotic resistant bacteria","volume":"11","author":"Firych","year":"2011","journal-title":"Post\u0119py Nauk MedycznycHh"},{"key":"10.1016\/j.gendis.2019.04.001_bib111","first-page":"22","article-title":"Mechanisms of antibiotic resistance in Pseudomonas aeruginosa","volume":"95","author":"Lambert","year":"2002","journal-title":"J R Soc Med"},{"key":"10.1016\/j.gendis.2019.04.001_bib112","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajic.2012.02.025","article-title":"Risk factors for extreme-drug .resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies","volume":"41","author":"Liew","year":"2013","journal-title":"Am J Infect Contr"},{"issue":"5","key":"10.1016\/j.gendis.2019.04.001_bib113","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00003246-199905000-00020","article-title":"Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System","volume":"27","author":"Richards","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.gendis.2019.04.001_bib114","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ijbiomac.2016.10.090","article-title":"Broad substrate affinity and catalytic diversity of fibrinolytic enzyme from Pheretima posthumous\u2014purification and molecular characterization study","volume":"95","author":"Verma","year":"2017","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"10.1016\/j.gendis.2019.04.001_bib115","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00726-015-2162-3","article-title":"Enzyme promiscuity in Earthworm serine protease- Substrate versatility and therapeutic potential","volume":"48","author":"Verma","year":"2016","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.gendis.2019.04.001_bib116","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1208\/s12249-015-0287-z","article-title":"Targeting therapeutics across the Blood-Brain Barrier (BBB), Prerequisite towards thrombolytic therapy for a cerebrovascular disorders-an overview and advancements AAPS","volume":"16","author":"Verma","year":"2015","journal-title":"Pharm Sci Tech"},{"issue":"11","key":"10.1016\/j.gendis.2019.04.001_bib117","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S2221-1691(13)60175-6","article-title":"Evaluation of the cytotoxic and antitumor activity of serine proteases isolated and purified from the Indian earthworm Pheretmia posthuma","volume":"3","author":"Verma","year":"2013","journal-title":"Asian Pac J Trop Biomed"},{"key":"10.1016\/j.gendis.2019.04.001_bib118","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.inf.0000069758.00079.d3","article-title":"Prospective incidence study of nosocomial infections in a pediatric intensive care unit","volume":"22","author":"Urrea","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"21","key":"10.1016\/j.gendis.2019.04.001_bib119","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.gendis.2019.04.001_bib120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/2110-5820-1-47","article-title":"The rising problem of antimicrobial resistance in the intensive care unit","volume":"1","author":"Brusselaers","year":"2011","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.gendis.2019.04.001_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.gendis.2019.04.001_bib122","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/646946","article-title":"Mortality attributable to nosocomial infections in the ICU","volume":"15","author":"Fagon","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.gendis.2019.04.001_bib123","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1034\/j.1399-6576.2003.00230.x","article-title":"Intensive care unit acquired infection: a prevalence and impact on morbidity and mortality","volume":"47","author":"Vosylius","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.gendis.2019.04.001_bib124","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00005373-199911000-00018","article-title":"Infection in hospitalized trauma patients: incidence, risk factors, and complications","volume":"47","author":"Papia","year":"1999","journal-title":"J Trauma"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304219300170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304219300170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:23:47Z","timestamp":1762449827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304219300170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2352304219300170"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2019.04.001","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Chongqing Medical University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}